Russian Journal of Clinical Ophthalmology
ISSN 2311-7729 (Print), 2619-1571 (Online)

Ophthalmic risk factors for primary open angle glaucoma

VAK

Scopus

E-libraryDimensions

russian citation indexULRICHS

roaddoaj

ebscoРГБ

CyberleninkaGoogle Scholar

Open accessCrossrefAntiplagiat

RMJ.ru

Impact factor - 0,760*

* Impact factor according to the SCIENCE INDEX 2022



DOI: 10.32364/2311-7729-2019-19-2-81-86

Primary open angle glaucoma (POAG) is a chronic progressive optic neuropathy, characterized by morphological changes in the optic nerve head and retinal nerve fiber layer. This review analyzes the development of the risk factors for POAG over several decades. The role of systemic diseases as a risk factor has been proven, and ophthalmological factors contributing to the progression of glaucoma are currently being actively studied. The most studied of these is ocular hypertension. A number of studies have shown an effect of both the average increase in the level of intraocular pressure (IOP) and its peak rises during the day on the progression of glaucomatous optic neuropathy (GON). Pseudoexfoliation syndrome and pigment dispersion syndrome, which are characterized by changes in the structures of the eye that increase the sensitivity of the nervous tissue to IOP level differences, can lead to increased IOP levels. An increase in the axial length of the eye associated with myopia is also considered to be a risk factor for the POAG development. In myopia, especially when high severity, there is a stretching of the fibrous tunic of the eye and changes in the structures of the fundus. These changes may be mistakenly diagnosed as glaucomatous, and may also contribute to the GON development. This review provides a summary of current data on the ophthalmic risk factors for the POAG development, which will improve the diagnosis of this disease. 

Keywords: primary open angle glaucoma, risk factor, ocular hypertension, pseudoexfoliation syndrome, pigment dispersion syndrome, myopia, myopic refraction. 

For citation: Erichev V.P., Onishchenko A.L., Kuroyedov A.V. et al. Ophthalmic risk factors for primary open angle glaucoma. Russian Journal of Clinical Ophthalmology. 2019;19(2):81–86. 

1Valery P. Erichev — MD, PhD, Professor, Head of Glaucoma Department, ORCHID iD 0000-0001-6842-7164;
2Aleksandr L. Onishchenko — MD, PhD, Professor, Deputy Director for Scientific Work, ORCHID iD 0000-0002-1549-5742;
3,4Aleksandr V. Kuroyedov — MD, PhD, Professor, Head of Ophthalmological Department, ORCHID iD 0000-0001-9606-0566;
1Sergey Yu. Petrov — MD, PhD, Senior Researcher of Glaucoma Department, ORCHID iD 0000-0001-6922-0464;
5Andrey Yu. Brezhnev — MD, PhD, Associate Professor of Ophthalmological Department, ORCHID iD 0000-0002-5597-983X;
1Alexey A. Antonov — MD, PhD, Senior Researcher of Glaucoma Department, ORCHID iD 0000-0002-5171-8261;
1Aleksandr A. Vitkov — resident physician, ORCHID iD 0000-0001-7735-9650;
6Yuliya K. Murakhovskaya — student, ORCHID iD 0000-0002-1251-6405.
1Scientific Research Institute of Eye Diseases. 11A, Rossolimo str., Moscow, 119021, Russian Federation.
2Novokuznetsk State Institute of Continuing Medical Education — branch of Russian Medical Academy of Continuing Professional Education. 5, Stroiteley prospect, Novokuznetsk, Kemerovo region, 654005, Russian Federation.
3 Pirogov Russian National Research Medical University. 1, Ostrovityanova str., Moscow, 117997, Russian Federation.
4Central Military Clinical Hospital named after P.V. Mandryka. 8A, B. Olenya str., Moscow, 107014, Russian Federation. 
5Kursk State Medical University. 3, Karl Marx str., Kursk, 305041, Russian Federation. 
6Sechenov University. 8/2, Trubetskaya str., Moscow, 119991, Russian Federation. 
Contact information: Aleksandr L. Onishchenkо, 
e-mail: onishchenkoal@mail.ruFinancial Disclosure: no author has a financial or property interest in any material or method mentioned. There is no conflict of interests. Received 13.12.2018.

   

References
1. Егоров Е.А., Еричев В.П., Онищенко А.Л. и др. Системные факторы риска развития первичной открытоугольной глаукомы. РМЖ. Клиническая офтальмология. 2018;3:140–145. DOI: 10.21689/2311-7729-2018-18-3-140-145. [Egorov E.A., Erichev V.P., Onishchenko A.L. et al. Systemic risk factors for the development of primary open-angle glaucoma. Russian Journal of Cliniсal Ophthalmology. 2018;3:140–145 (in Russ.)]. DOI: 10.21689/2311-7729-2018-18-3-140-145.
2. Le A., Mukesh B.N., McCarty C.A., Taylor H.R. Risk factors associated with the incidence of openё-angle glaucoma: the visual impairment project. Invest Ophthalmol Vis Sci. 2003;44(9):3783–3789.
3. Czudowska M.A., Ramdas W.D., Wolfs R.C. et al. Incidence of glaucomatous visual field loss: a ten-year follow-up from the Rotterdam Study. Ophthalmology. 2010;117(9):1705–1712. DOI: 10.1016/j.ophtha.2010.01.034.
4. Nemesure B., Honkanen R., Hennis A. et al. Barbados Eye Studies G. Incident open-angle glaucoma and intraocular pressure. Ophthalmology. 2007;114(10):1810–1815. DOI: 10.1016/j.ophtha.2007.04.003.
5. Sommer A., Tielsch J.M., Katz J. et al. Relationship between intraocular pressure and primary open angle glaucoma among white and black Americans. The Baltimore Eye Survey. Arch Ophthalmol. 1991;109(8):1090–1095.
6. Kass M.A., Heuer D.K., Higginbotham E.J. et al. The Ocular Hypertension Treatment Study: a randomized trial determines that topical ocular hypotensive medication delays or prevents the onset of primary open-angle glaucoma. Arch Ophthalmol. 2002;120(6):701–713; discussion 829–730.
7. Leske M.C., Heijl A., Hyman L. et al. Predictors of long-term progression in the early manifest glaucoma trial. Ophthalmology. 2007;114(11):1965–1972. DOI: 10.1016/j.ophtha.2007.03.016.
8. The Advanced Glaucoma Intervention Study (AGIS): 7. The relationship between control of intraocular pressure and visual field deterioration.The AGIS Investigators. Am J Ophthalmol. 2000;130(4):429–440.
9. Sood V., Ramanathan U.S. Self-Monitoring of Intraocular Pressure Outside of Normal Office Hours Using Rebound Tonometry: Initial Clinical Experience in Patients With Normal Tension Glaucoma. J Glaucoma. 2016;25(10):807–811. DOI: 10.1097/IJG.0000000000000424.
10. De Moraes C.G., Juthani V.J., Liebmann J.M. et al. Risk factors for visual field progression in treated glaucoma. Arch Ophthalmol. 2011;129(5):562–568. DOI: 10.1001/archophthalmol.2011.72.
11. Asrani S., Zeimer R., Wilensky J. et al.Large diurnal fluctuations in intraocular pressure are an independent risk factor in patients with glaucoma. J Glaucoma. 2000;9(2):134–142.
12. European Glaucoma Society Terminology and Guidelines for Glaucoma, 4th Edition — Chapter 2: Classification and terminologySupported by the EGS Foundation: Part 1: Foreword; Introduction; Glossary; Chapter 2 Classification and Terminology. Br J Ophthalmol. 2017;101(5):73–127. DOI: 10.1136/bjophthalmol-2016-EGSguideline.003.
13. Ronci M., Sharma S., Martin S. et al. MALDI MS imaging analysis of apolipoprotein E and lysyl oxidase-like 1 in human lens capsules affected by pseudoexfoliation syndrome. J Proteomics. 2013;82:27–34. DOI: 10.1016/j.jprot.2013.01.008.
14. Sharma S., Chataway T., Burdon K.P. et al. Identification of LOXL1 protein and Apolipoprotein E as components of surgically isolated pseudoexfoliation material by direct mass spectrometry. Exp Eye Res. 2009;89(4):479–485. DOI: 10.1016/j.exer.2009.05.001.
15. Schlotzer-Schrehardt U., Pasutto F., Sommer P. et al. Genotype-correlated expression of lysyl oxidase-like 1 in ocular tissues of patients with pseudoexfoliation syndrome/glaucoma and normal patients. Am J Pathol. 2008;173(6):1724–1735. DOI: 10.2353/ajpath.2008.080535.
16. Schlotzer-Schrehardt U., Zenkel M., Kuchle M. et al.Role of transforming growth factor-beta1 and its latent form binding protein in pseudoexfoliation syndrome. Exp Eye Res. 2001;73(6):765–780. DOI: 10.1006/exer.2001.1084.
17. Helbig H., Schlotzer-Schrehardt U., Noske W. et al. Anterior-chamber hypoxia and iris vasculopathy in pseudoexfoliation syndrome. Ger J Ophthalmol. 1994;3(3):148–153.
18. Kang J.H., Loomis S.J., Wiggs J.L. et al. A prospective study of folate, vitamin B6, and vitamin B12 intake in relation to exfoliation glaucoma or suspected exfoliation glaucoma. JAMA Ophthalmol. 2014;132(5):549–559. DOI: 10.1001/jamaophthalmol.2014.100.
19. Gonen K.A., Gonen T., Gumus B. Renal artery stenosis and abdominal aorta aneurysm in patients with pseudoexfoliation syndrome. Eye (Lond). 2013;27(6):735–741. DOI: 10.1038/eye.2013.56.
20. Ritch R. Ocular and systemic manifestations of exfoliation syndrome. J Glaucoma. 2014;23(8 Suppl 1):1–8. DOI: 10.1097/IJG.0000000000000119.
21. Ritch R., Schlotzer-Schrehardt U. Exfoliation syndrome. Surv Ophthalmol. 2001;45(4):265–315. DOI: 10.1097/ICO.0b013e318213a80d.
22. Yenerel N.M., Gorgun E., Kucumen R.B. et al. Corneal biomechanical properties of patients with pseudoexfoliation syndrome. Cornea. 2011;30(9):983–986. DOI: 10.15537/smj.2015.1.9121.
23. Al-Saleh S.A., Al-Dabbagh N.M., Al-Shamrani S.M. et al. Prevalence of ocular pseudoexfoliation syndrome and associated complications in Riyadh, Saudi Arabia. Saudi Med J. 2015;36(1):108–112.
24. Баранов В.И., Брежнев А.Ю. Псевдоэксфолиативный синдром в Центральной России: клинико-эпидемиологическое исследование. Российский офтальмологический журнал. 2012;5(1):22–24. [Baranov V.I., Brezhnev A. Yu. Pseudoexfoliation syndrome in Central Russia: a clinical and epidemiological study. Rossiyskiy oftal'mologicheskiy zhurnal. 2012;5(1):22–24 (in Russ.)].
25. Siddiqui Y., Ten Hulzen R.D., Cameron J.D. et al. What is the risk of developing pigmentary glaucoma from pigment dispersion syndrome? Am J Ophthalmol. 2003;135(6):794–799.
26. Andersen J.S., Pralea A.M., DelBono E.A. et al. A gene responsible for the pigment dispersion syndrome maps to chromosome 7q35-q36. Arch Ophthalmol. 1997;115(3):384–388.
27. Moroi S.E., Lark K.K., Sieving P.A. et al. Long anterior zonules and pigment dispersion. Am J Ophthalmol. 2003;136(6):1176–1178.
28. Gomez Goyeneche H.F., Hernandez-Mendieta D.P., Rodriguez D.A. et al. Pigment Dispersion Syndrome Progression to Pigmentary Glaucoma in a Latin American Population. J Curr Glaucoma Pract. 2015;9(3):69–72. DOI: 10.5005/jp-journals-10008-1187.
29. Musch D.C., Shimizu T., Niziol L.M. et al. Clinical characteristics of newly diagnosed primary, pigmentary and pseudoexfoliative open-angle glaucoma in the Collaborative Initial Glaucoma Treatment Study. Br J Ophthalmol. 2012;96(9):1180–1184. DOI: 10.1136/bjophthalmol-2012-301820.
30. Qing G., Wang N. Clinical signs and characteristics of pigmentary glaucoma in Chinese. Jpn J Ophthalmol. 2008;52(3):162–166. DOI: 10.1007/s10384-008-0525-y.
31. Scheie H.G., Cameron J.D. Pigment dispersion syndrome: a clinical study. Br J Ophthalmol. 1981;65(4):264–269. DOI: 10.1136/bjo.65.4.264.
32. Liu L., Ong E.L., Crowston J. The concave iris in pigment dispersion syndrome. Ophthalmology. 2011;118(1):66–70. DOI: 10.1016/j.ophtha.2010.04.039.
33. Щуко А.Г., Юрьева Т.Н. Синдром пигментной дисперсии. Часть 1. Закономерности формирования, обоснование клинической классификации. Глаукома. 2012;(4):39–45. [Schuko A.G., Yuriev T.N. Syndrome pigment dispersion. Part 1. Patterns of formation, justification of the clinical classification. Glaukoma. 2012;(4):39–45 (in Russ.)].
34. Passo M.S., Elliot D.L., Goldberg L. Long-term effects of exercise conditioning on intraocular pressure in glaucoma suspects. J Glaucoma. 1992;1(1):39–41.
35. Hashemi H., Fotouhi A., Yekta A. et al. Global and regional estimates of prevalence of refractive errors: Systematic review and meta-analysis. J Curr Ophthalmol. 2018;30(1):3–22. DOI: 10.1016/j.joco.2017.08.009.
36. Wong T.Y., Klein B.E., Klein R. et al. Refractive errors, intraocular pressure, and glaucoma in a white population. Ophthalmology. 2003;110(1):211–217.
37. Wong Y.Z., Lam A.K. The roles of cornea and axial length in corneal hysteresis among emmetropes and high myopes: a pilot study. Curr Eye Res. 2015;40(3):282–289. DOI: 10.3109/02713683.2014.922193.
38. Gaspar R., Pinto L.A., Sousa D.C. Corneal properties and glaucoma: a review of the literature and meta-analysis. Arq Bras Oftalmol. 2017;80(3):202–206. DOI: 10.5935/0004-2749.20170050.
39. Jonas J.B., Ohno-Matsui K., Panda-Jonas S. Optic Nerve Head Histopathology in High Axial Myopia. J Glaucoma. 2017;26(2):187–193. DOI: 10.1097/IJG.0000000000000574.
40. Doshi A., Kreidl K.O., Lombardi L. et al. Nonprogressive glaucomatous cupping and visual field abnormalities in young Chinese males. Ophthalmology. 2007;114(3):472–479. DOI: 10.1016/j.ophtha.2006.07.036.
41. Oh S.H., Chung S.K., Lee N.Y. Topographical Analysis of Non-Glaucomatous Myopic Optic Discs Using a Confocal Scanning Laser Ophthalmoscope (TopSS). Semin Ophthalmol. 2015;30(5–6):397–409. DOI: 10.3109/08820538.2014.912339.
42. Kang S.H., Hong S.W., Im S.K. et al. Effect of myopia on the thickness of the retinal nerve fiber layer measured by Cirrus HD optical coherence tomography. Invest Ophthalmol Vis Sci. 2010;51(8):4075–4083. DOI: 10.1167/iovs.09-4737.
43. Lee S., Han S.X., Young M. et al. Optic nerve head and peripapillary morphometrics in myopic glaucoma. Invest Ophthalmol Vis Sci. 2014;55(7):4378–4393. DOI: 10.1167/iovs.14-14227.
44. Savini G., Barboni P., Parisi V., Carbonelli M. The influence of axial length on retinal nerve fibre layer thickness and optic-disc size measurements by spectral-domain OCT. Br J Ophthalmol. 2012;96(1):57–61. DOI: 10.1136/bjo.2010.196782.
45. Jonas J.B., Dichtl A. Optic disc morphology in myopic primary open-angle glaucoma. Graefes Arch Clin Exp Ophthalmol. 1997;235(10):627–633.
46. Marcus M.W., de Vries M.M., Junoy Montolio F.G., Jansonius N.M. Myopia as a risk factor for open-angle glaucoma: a systematic review and meta-analysis. Ophthalmology. 2011;118(10):1989–1994 e1982. DOI: 10.1016/j.ophtha.2011.03.012.
47. Shen L., Melles R.B., Metlapally R. et al. The Association of Refractive Error with Glaucoma in a Multiethnic Population. Ophthalmology. 2016;123(1):92–101. DOI: 10.1016/j.ophtha.2015.07.002.



License Creative Commons
This work is licensed under a Creative Commons «Attribution» 4.0 License.
Previous article
Next article

Register now and get access to useful services:
  • Загрузка полнотекстовых версий журналов (PDF)
  • Медицинские калькуляторы
  • Список избранных статей по Вашей специальности
  • Видеоконференции и многое другое

С нами уже 50 000 врачей из различных областей.
Присоединяйтесь!
[Error] 
Call to undefined function get_registration_form_description_popup() (0)
/home/c/cb72209/clinopht.com/public_html/en/include/reg_form.php:89
#0: include
	/home/c/cb72209/clinopht.com/public_html/bitrix/modules/main/classes/general/main.php:1419
#1: CAllMain->IncludeFile(string)
	/home/c/cb72209/clinopht.com/public_html/local/templates/.default/include/cl-footer.php:217
#2: include_once(string)
	/home/c/cb72209/clinopht.com/public_html/local/templates/cl_inner_sidebar_en/footer.php:11
#3: include_once(string)
	/home/c/cb72209/clinopht.com/public_html/bitrix/modules/main/include/epilog_before.php:93
#4: require(string)
	/home/c/cb72209/clinopht.com/public_html/bitrix/modules/main/include/epilog.php:2
#5: require_once(string)
	/home/c/cb72209/clinopht.com/public_html/bitrix/footer.php:4
#6: require(string)
	/home/c/cb72209/clinopht.com/public_html/en/articles/index.php:150
#7: include_once(string)
	/home/c/cb72209/clinopht.com/public_html/bitrix/modules/main/include/urlrewrite.php:184
#8: include_once(string)
	/home/c/cb72209/clinopht.com/public_html/bitrix/urlrewrite.php:2
----------